drugset / Trial / NCT05511558
A Study of the Absorption, Metabolism, and Excretion of [14C]-Fosgonimeton (ATH-1017)
Phase 1
Completed
8 enrolled
LeonaBio
Alturas Analytics, Inc. · collabLabcorp Corporation of America Holdings, Inc · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase 1, open-label, nonrandomized, single-dose human, absorption, metabolism, and excretion study of \[14C\]-Fosgonimeton
Timeline
- Start
- 2022-07-13
- Primary completion
- 2022-10-18
- Completion
- 2022-10-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | fosgonimeton | Small molecule | — | Subcutaneous |
Indications
No indication recorded.